NRG1 and schizophrenia: Notably, miR-382-5p has also been shown to target NRG1 in spinal cord injury [22] and its involvement extends to the pathogenesis of various neurological disorders, including migraine [43], schizophrenia [44], and cerebral ischemia–reperfusion injury [45].